Vialwirebiotech, curated
September 30, 2026, 1:36 AM
September 26, 2026
- 12:00 AM · FT — Pharmaceuticals12:00 AMMedicines run short in Iran under US sanctions — FT — Pharmaceuticals
September 25, 2026
- 9:00 PM · SCMP — Tech
- 6:00 PM · Nikkei Asia6:00 PMJapan herbal remedy makers seek to reduce China from supply chain — Nikkei Asia
- 1:50 PM · STAT News
- 1:00 PM · FT — Pharmaceuticals1:00 PMDirectors’ Deals: AstraZeneca’s Soriot in a major show of faith — FT — Pharmaceuticals
- 12:00 PM · BioWorld12:00 PMRemynd raises €3.5M to get novel Alzheimer’s program back on track — BioWorld
- 12:00 PM · BioWorld12:00 PMAcadia push in ADP still alive after near miss in phase II — BioWorld
- 12:00 PM · BioWorld12:00 PMNanexa’s $1.3B drug delivery deal offers Novo longer-acting peptides — BioWorld
- 12:00 PM · BioWorld12:00 PMJury awards $90M to Nektar in Lilly dispute over rezpeg — BioWorld
- 11:25 AM · STAT News11:25 AMSTAT+: Lilly wins approval for once-weekly insulin shot — STAT News
- 9:51 AM · Pharmaceutical Technology9:51 AMAptar Pharma and Macquarie University partner on drug delivery project — Pharmaceutical Technology
- 9:50 AM · Pharmaceutical Executive9:50 AM<![CDATA[FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMXtalpi submits IND for KQTD-126 for chronic intestinal pain — BioWorld
- 9:00 AM · BioWorld9:00 AMSotio’s SOT-106 designated orphan drug for soft tissue sarcoma — BioWorld
- 9:00 AM · BioWorld9:00 AMBristol Myers Squibb patents new NIK inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMAptevo advances APVO-451 toward IND-enabling studies — BioWorld
- 9:00 AM · BioWorld9:00 AMPrime Medicine’s PM-647 gains IND approval for AATD — BioWorld
- 9:00 AM · BioWorld9:00 AMSaniona eyes IND submission for SAN-2465 — BioWorld
- 6:47 AM · Drug Discovery World6:47 AMEC approves first treatment for rare neurodegenerative disease — Drug Discovery World
- 6:30 AM · SCMP — Tech6:30 AMChina and EU deadlocked on medical devices, still talking on PHEV curbs: source — SCMP — Tech
- 5:10 AM · Pharmaceutical Technology5:10 AMAmberstone and Henlius agree to develop solid-tumour T-cell engagers — Pharmaceutical Technology
- 5:09 AM · Drug Discovery World5:09 AMOna Therapeutics moves to Phase I with ADC for advanced cancers — Drug Discovery World
- 4:00 AM · Labiotech (EU)4:00 AMTheialife’s race to bring a childhood myopia treatment to market — Labiotech (EU)
- 2:50 AM · BBC — Health2:50 AMHow a rapid new test is helping brain tumour patients — BBC — Health
- 12:00 AM · FT — Pharmaceuticals12:00 AMPharma deal fever boosts flurry of highly complex mergers — FT — Pharmaceuticals
September 24, 2026
- 8:36 PM · BioPharma Dive8:36 PMRNAi drug specialist ADARx raises $446M IPO — BioPharma Dive
- 5:08 PM · BioPharma Dive5:08 PMGrail multicancer detection test wins FDA advisers’ backing — BioPharma Dive
- 4:46 PM · BioPharma Dive4:46 PMFDA nominee Overton parries vaccine questions at Senate hearing — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAn instinct about Atavistik? Roche signs $1.9B-plus deal — BioWorld
- 12:00 PM · BioWorld12:00 PMAwiqli insulin, this time for Lilly, with FDA-cleared Onswik — BioWorld
- 12:00 PM · BioWorld12:00 PMEnveda raises a $311M series E for pipeline of plant-discovered molecules — BioWorld
- 12:00 PM · BioWorld12:00 PMDME red flag in Merck Brunello phase III? Surrozen finishes rich — BioWorld
- 12:00 PM · BioWorld12:00 PMFGFR2 inhibitor Lyrfigtu wins FDA approval for bile duct cancer — BioWorld
- 12:00 PM · BioWorld12:00 PMKasvu’s €30M series A to take novel antidepressant into the clinic — BioWorld
- 11:34 AM · BioPharma Dive11:34 AMMerck reveals study success, and possible safety worries, for eye drug hopeful — BioPharma Dive
- 10:57 AM · STAT News
- 9:57 AM · Pharmaceutical Technology9:57 AMEli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare — Pharmaceutical Technology
- 9:52 AM · STAT News9:52 AMSTAT+: Kyverna’s cell therapy shows lasting autoimmune benefit — STAT News
- 9:21 AM · STAT News9:21 AMSTAT+: The rise of the AI-native radiology practice — STAT News
- 6:30 AM · STAT News6:30 AMSTAT+: Why Gilead can’t stop talking about its ambitions in immunology — STAT News
- 6:22 AM · Pharmaceutical Technology6:22 AMPodcast: How Sandoz plans to harness its “golden decade” — Pharmaceutical Technology
- 5:46 AM · Drug Discovery World5:46 AMPhase III study supports lumateperone use in bipolar mania — Drug Discovery World
- 5:14 AM · Pharmaceutical Technology5:14 AMGenialis and Inventia to enhance pancreatic cancer treatment testing — Pharmaceutical Technology
- 4:29 AM · Pharmaceutical Technology4:29 AMBasecamp Research secures $140m for AI-driven therapies — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMEC approves first triple-combination therapy for asthma maintenance — Drug Discovery World
- 2:29 AM · SCMP — Tech2:29 AMChinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days — SCMP — Tech